Starpharma Holdings Limited (SPHRF)
OTHER OTC:SPHRF

Starpharma Holdings Limited (SPHRF) Income Statement

11 Followers

Starpharma Holdings Limited Income Statement

Last quarter (Q4 2022), Starpharma Holdings Limited's total revenue was AU$―, a decrease of ― from the same quarter last year. In Q4, Starpharma Holdings Limited's net income was AU$―. See Starpharma Holdings Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 23Jun 22Jun 21Jun 20Jun 19
Total Revenue
--AU$ 4.68MAU$ 1.80MAU$ 6.03MAU$ 1.65M
Cost of Revenue
--AU$ 2.78MAU$ 791.00KAU$ 890.00KAU$ 251.00K
Gross Profit
--AU$ 1.91MAU$ 1.01MAU$ 5.14MAU$ 1.40M
Operating Expense
--AU$ 19.62MAU$ 23.36MAU$ 21.81MAU$ 16.72M
Operating Income
--AU$ -17.71MAU$ -22.36MAU$ -16.67MAU$ -15.32M
Net Non Operating Interest Income Expense
--AU$ 217.00KAU$ 353.00KAU$ 523.00KAU$ 1.06M
Other Income Expense
--AU$ 263.00KAU$ 1.34MAU$ 559.00KAU$ 12.00K
Pretax Income
--AU$ -16.15MAU$ -19.73MAU$ -14.68MAU$ -14.25M
Tax Provision
--AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
--AU$ -16.15MAU$ -19.73MAU$ -14.68MAU$ -14.25M
Basic EPS
--AU$ -0.04AU$ -0.05AU$ -0.04AU$ -0.04
Diluted EPS
--AU$ -0.04AU$ -0.05AU$ -0.04AU$ -0.04
Basic Average Shares
--AU$ 406.90MAU$ 396.88MAU$ 372.23MAU$ 371.29M
Diluted Average Shares
--AU$ 406.90MAU$ 396.88MAU$ 372.23MAU$ 371.29M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
------
Net Income From Continuing And Discontinued Operation
--AU$ -16.15MAU$ -19.73MAU$ -14.68MAU$ -14.25M
Normalized Income
--AU$ -16.15MAU$ -19.73MAU$ -14.68MAU$ -14.25M
Interest Expense
------
EBIT
--AU$ -17.71MAU$ -22.36MAU$ -16.67MAU$ -15.32M
EBITDA
-AU$ -17.04MAU$ -16.63MAU$ -21.42MAU$ -15.76MAU$ -15.32M
Currency in AUD

Starpharma Holdings Limited Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis